Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07119593

Exercise Intensity

Boosting Myocardial Preconditioning With High-Intensity Intradialytic Exercise: A Preliminary Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

Patients receiving regular hemodialysis (HD) treatments are at a higher risk of cardiovascular events and death as HD can cause a decrease in the pumping of the heart during treatment called 'stunning'. Intradialytic exercise has emerged as a safe and effective non-drug approach to improve cardiovascular health and is now recommended for patients undergoing HD. It is currently advised that HD patients engage in at least 30 minutes of moderate to vigorous exercise three times per week. This study will evaluate the impact of exercise intensity in the HD population and determine if high impact exercise can offer better protection to the heart against HD-induced myocardial stunning.

Detailed description

This will be the first randomized, cross-controlled trial evaluating the impact of exercise intensity in the HD population. If the efficacy of cardiovascular protection is proven, it could be developed as a therapeutic option in the dialysis population.

Conditions

Interventions

TypeNameDescription
OTHERIntradialytic CyclingIntradialytic exercise has emerged as a safe and effective non-drug therapeutic approach to improve cardiovascular health and is now recommended for people undergoing hemodialysis treatment. Administration of a higher intensity exercise could offer better cardio-protective mechanisms and if the efficacy of cardiovascular protection is proven, it could be developed as a therapeutic option in the dialysis population.

Timeline

Start date
2025-09-22
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-08-13
Last updated
2025-09-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT07119593. Inclusion in this directory is not an endorsement.